As systemic trans-signalling dominates in acute inflammatory responses such as sepsis and COVID-19 [33], all further in vitro experiments were performed with the combination of IL-6 (1 ng/ml) and sIL-6R (50 ng/ml). The gene discussed is IL6R; the disease is COVID-19.